The results showed that CXCL12 derived from fibroblasts significantly enhanced the invasion of cancer cells and the migration of vascular endothelial cells, and this enhancement could be blocked by CXCL12Ab and CXCR4siRNA. Here, CXCL12 is linked to cancer.